Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […]

Related Keywords

Amyw Schulman , , Securities Exchange Commission , Allspring Global Investments Holdings , Nasdaq , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Down , Alnylam Pharmaceuticals Inc , Quent Capital , Citigroup , Investment Management , Wells Fargo Company , Morgan Stanley , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Get Free Report , Director Amy , Exchange Commission , Pharmaceuticals Stock Down , Global Investments Holdings , Crest Partners , Alnylam Pharmaceuticals Daily ,